What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Leptospirosis in Dogs: Clinical Signs, Diagnostics, and One Health Implications

Introduction

Leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. In domestic dogs, infection can result in acute febrile illness, renal and hepatic failure, pulmonary hemorrhage, and death. The disease has gained increased recognition due to expanding urban and peri-urban transmission cycles, climate change facilitating environmental survival of leptospires, and the emergence of serovars not historically covered by traditional vaccines [1, 2]. This article provides an exhaustive reference on the clinical presentation, diagnostic approaches, therapeutic strategies, and One Health implications of canine leptospirosis, with emphasis on the molecular mechanisms of host-pathogen interaction and the biophysical principles underlying diagnostic assays.

Etiology and Serovar Diversity

Leptospira are Gram-negative, obligate aerobic spirochetes belonging to the phylum Spirochaetes. Pathogenic species are classified within the L. interrogans sensu lato group, with over 300 serovars defined by lipopolysaccharide (LPS) antigenic structure. Serovars are aggregated into serogroups based on shared agglutinating antigens [3]. In dogs, the most frequently implicated serovars include:

Leptospira interrogans serovar Canicola
L. interrogans serovar Icterohaemorrhagiae
L. kirschneri serovar Grippotyphosa
L. interrogans serovar Pomona
L. borgpetersenii serovar Ballum
L. interrogans serovar Australis
L. noguchii serovar Louisiana

Serovar distribution varies geographically and temporally. In North America and Europe, serovars Grippotyphosa and Pomona have emerged as common causes of canine disease, partly due to wildlife reservoirs such as raccoons, skunks, and opossums [4, 5]. The antigenic diversity complicates both diagnosis and vaccination, as cross-protection between serogroups is minimal.

Pathogenesis and Clinical Signs

Infection occurs when intact leptospires penetrate mucous membranes or abraded skin and enter the bloodstream. The outer membrane contains LPS, lipoproteins, and hemolysins that activate endothelial cells and induce a proinflammatory cascade mediated by Toll-like receptor 2 (TLR2) and TLR4 [6]. Bacteremia lasts approximately 4 to 7 days, during which organisms disseminate to target organs, particularly the renal tubules, hepatic parenchyma, and pulmonary endothelium.

The pathophysiology of organ injury involves both direct bacterial invasion and host immune responses.

Acute Renal Injury

Leptospires colonize the proximal renal tubular epithelium through adhesion mediated by outer membrane proteins such as LigA, LigB, and LipL32 [7]. Tubular necrosis results from ischemia induced by interstitial edema and from direct cytotoxic effects of leptospiral enzymes. Acute kidney injury (AKI) manifests as oliguria or anuria, azotemia, and electrolyte imbalances. Nonoliguric renal failure is also common in dogs [8].

Hepatic Involvement

Hepatic injury occurs through intercellular invasion of hepatocytes and disruption of bile canaliculi, leading to cholestasis. Hyperbilirubinemia is frequent but not invariable; icterus is more characteristic of serovar Icterohaemorrhagiae infection [9]. Serum liver enzyme activities (alanine aminotransferase, alkaline phosphatase) may be mildly to moderately elevated.

Pulmonary Manifestations

Pulmonary hemorrhage, often termed severe pulmonary hemorrhagic syndrome (SPHS), is a life-threatening complication. It results from immune complex deposition and endothelial damage causing alveolar hemorrhage without thrombocytopenia [10]. Affected dogs present with tachypnea, hemoptysis, and radiographic evidence of diffuse interstitial to alveolar patterns.

Other Clinical Signs

Fever, depression, anorexia, vomiting, diarrhea, myalgia, polyuria/polydipsia, stiff gait, and uveitis are common. Subclinical infections also occur, particularly in vaccinated animals or those infected with less virulent serovars [11]. The incubation period ranges from 4 to 14 days.

Diagnostic Approaches

A combination of clinicopathologic findings, serology, molecular methods, and culture is used for diagnosis. Each modality has distinct biophysical and practical advantages and limitations.

Clinicopathologic Testing

Complete blood count (CBC) may reveal neutrophilic leukocytosis with left shift and thrombocytopenia. Serum biochemistry shows azotemia, hyperbilirubinemia, increased liver enzyme activities, and often hyperphosphatemia due to renal impairment. Urinalysis typically demonstrates proteinuria, hematuria, pyuria, and granular casts [12].

Automated impedance analyzers record these parameters, but leptospirosis-induced thrombocytopenia should be confirmed by blood smear evaluation to rule out pseudothrombocytopenia from platelet clumping.

Serology: Microscopic Agglutination Test (MAT)

The MAT is the reference standard serologic assay. It detects antibodies against a panel of live leptospiral serovars representing locally relevant serogroups. Serial twofold dilutions of patient serum are incubated with each serovar; agglutination is assessed by dark-field microscopy. A titer of 1:100 or greater in a single sample, or a fourfold rise in paired samples, supports active infection [13].

Despite its utility, MAT has several limitations. It requires maintaining live leptospiral cultures, which is technically demanding and biohazardous. Cross-reactivity between serogroups is common, and early antibiotic administration can blunt the antibody response. Sensitivity is highest in the second week of illness [14].

Enzyme-Linked Immunosorbent Assay (ELISA)

Detection of IgM and IgG antibodies against outer membrane antigens (e.g., LipL32, LipL41) is available as commercial ELISA kits. These methods offer rapid turnaround and do not require live cultures. However, they cannot differentiate serogroups, and positive results may reflect previous vaccination or past exposure [15]. The assay physics rely on antigen-antibody binding and enzymatic colorimetric detection, analogous to the p27 antigen detection ELISA used for Feline Leukemia Virus (see that article for comparable enzyme-substrate principles).

Molecular Diagnostics: Polymerase Chain Reaction (PCR)

PCR targeting the 16S rRNA gene, secY gene, or lipL32 gene provides high sensitivity and specificity for active infection. Real-time quantitative PCR (qPCR) allows pathogen load quantification. Blood, urine, cerebrospinal fluid, or tissue samples can be used. Urine is preferred in the leptospiruric phase (day 7 to 14 post infection), while blood is more sensitive during the bacteremic phase (first week) [16].

The biophysical mechanism of PCR involves thermal cycling (denaturation at 94-96°C, annealing at 50-65°C, extension at 72°C) to exponentially amplify target DNA. Fluorescent probes (e.g., TaqMan) enable real-time quantification. Multiplex PCR panels can simultaneously detect multiple serogroups through serovar-specific primers, though complete serovar identification still requires sequencing [17].

Dark-Field Microscopy and Culture

Direct visualization of leptospires in dark-field microscopy is useful in acute samples but lacks sensitivity. Culture requires specialized media such as Ellinghausen-McCullough-Johnson-Harris (EMJH) medium; growth may take weeks and is rarely performed in clinical practice [18].

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended decision tree for canine leptospirosis diagnosis.

flowchart TD
    A[Clinical suspicion: fever, renal/hepatic signs, exposure history], > B{Acute onset <7 days?}
    B, Yes, > C[Collect blood for PCR + MAT acute titer]
    B, No, > D[Collect urine for PCR + MAT paired titers]
    C, > E[PCR positive?]
    E, Yes, > F[Confirm diagnosis, initiate treatment]
    E, No, > G[MAT acute titer >=1:100?]
    G, Yes, > F
    G, No, > H[Mild suspicion: re-test 7-14 days]
    D, > I[Urine PCR positive?]
    I, Yes, > F
    I, No, > J[MAT acute titer >=1:100?]
    J, Yes, > F
    J, No, > K[MAT convalescent titer fourfold rise?]
    K, Yes, > F
    K, No, > L[Consider alternative diagnosis]

The diagram integrates both molecular and serologic assays to maximize diagnostic yield. In cases of pulmonary hemorrhage, PCR on bronchoalveolar lavage fluid may be advisable.

Treatment and Antibiotic Therapy

Treatment comprises supportive care and antimicrobial therapy aimed at eliminating leptospires and reducing bacterial shedding.

Antibiotic Regimens

Doxycycline is the drug of choice for treatment of acute leptospirosis in dogs. It achieves excellent tissue penetration and bacteriostatic action by inhibiting protein synthesis via 30S ribosomal subunit binding. The recommended dosage is 5 mg/kg orally every 12 hours or 10 mg/kg intravenously once daily for 2 to 3 weeks [19].

In the presence of vomiting or renal impairment, intravenous ampicillin (10-20 mg/kg every 6-8 hours) or penicillin G (25,000-40,000 U/kg every 12 hours) can be used initially, followed by oral doxycycline after stabilization [20]. For elimination of the renal carrier state and prevention of chronic shedding, doxycycline is required; penicillins do not reliably clear renal colonization [21].

Supportive Care

Fluid therapy with balanced crystalloids (e.g., lactated Ringer's solution) is essential to correct dehydration, electrolyte disturbances, and acidosis. In AKI cases, careful monitoring of urine output and central venous pressure is necessary to avoid fluid overload. Hemodialysis or peritoneal dialysis may be required in anuric or severe oliguric patients [22].

For SPHS, oxygen therapy, mechanical ventilation with positive end-expiratory pressure, and blood transfusion may be indicated. Anti-inflammatory dosing of methylprednisolone has been proposed but remains controversial [23].

Prevention of Environmental Contamination

Hospitalized dogs should be considered highly contagious. Urine, blood, and bedding should be handled using barrier nursing precautions. Gloves, goggles, and disinfectants effective against leptospires (e.g., 1% sodium hypochlorite, 2% glutaraldehyde) must be used [24].

Vaccination

Vaccination is a cornerstone of prevention. Bacterin-based vaccines containing inactivated whole leptospires of specific serovars are available. Because protection is serogroup specific, vaccines should include the locally prevalent serovars. Most currently available canine vaccines contain serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona [25].

The immunologic mechanism involves humoral antibody responses against LPS and outer membrane proteins, leading to opsonization and complement-mediated killing. Cell-mediated immunity also contributes but is less characterized. Vaccination does not prevent infection entirely but reduces clinical severity and shedding duration [26].

Adverse reactions occur more frequently with leptospiral bacterins than with other canine vaccines, including immediate hypersensitivity and delayed local reactions. Modified vaccination protocols (e.g., using an initial priming dose followed by boosters at 2-4 week intervals) can mitigate risk [27].

One Health Implications

Leptospirosis is a classic One Health disease, affecting humans, dogs, livestock, and wildlife. Dogs can serve as sentinels for environmental contamination and as direct sources of infection for owners [28].

Zoonotic Risk

Transmission from dogs to humans occurs through direct contact with urine or contaminated water. The same serovars affect both species. Human infection presents similarly with febrile illness, jaundice, renal failure, and pulmonary hemorrhage (Weil's disease). A study reported that 30% of dogs with leptospirosis lived in households with children, indicating substantial exposure risk [29]. Veterinary personnel are at particular occupational risk [30].

Wildlife Reservoir Maintenance

Synanthropic wildlife such as raccoons, rodents, opossums, skunks, and white-tailed deer shed leptospires into surface water, creating a maintenance cycle that infects dogs and humans. The interface between domestic pets and these reservoirs is a critical control point [31]. For example, Tick-Borne Parasites in White-Tailed Deer describes similar contact points for pathogen transmission, and the principle of wildlife-livestock interface applies equally to leptospirosis.

Environmental Persistence

Leptospires survive in moist soil, puddles, and slow-moving freshwater for weeks to months. Their motility is powered by periplasmic flagella that rotate within the spirochete cell body, enabling directed movement in viscous environments. The biophysical mechanism of survival involves a thick peptidoglycan layer and ability to enter a viable but nonculturable (VBNC) state under desiccation stress [32]. Climate change with increased flooding events facilitates dissemination [33].

Diagnostic Surveillance

One Health surveillance requires coordinated sampling of dogs, wildlife, and water sources. PCR and serological surveys in canine populations can predict human outbreak risk. In resource-limited settings, modified MAT methods and direct urine antigen detection using lateral flow assays are under development [34].

Antimicrobial Resistance and Emerging Serovars

Although antimicrobial resistance in Leptospira remains relatively rare, reports of reduced susceptibility to doxycycline and penicillin have emerged from Asia and South America [35]. The molecular mechanisms involve target alterations in the 30S ribosomal subunit or efflux pumps. Ongoing surveillance using minimum inhibitory concentration (MIC) testing is recommended [36].

The emergence of serovars not included in standard vaccines, such as L. borgpetersenii serovar Ballum, L. noguchii, and L. santarosai, complicates control. Whole-genome sequencing of canine isolates has revealed recombination events between serovars, potentially altering antigenicity and virulence [37].

Future Directions

Advances in multiplex real-time PCR and high-throughput sequencing enable rapid, serovar-level identification directly from clinical specimens. Metagenomic sequencing may eventually replace conventional PCR panels, allowing unbiased detection of all leptospiral species [38]. Computational models integrating canine surveillance data, environmental data, and human case reports are being developed for outbreak forecasting, as discussed in the article on Porcine Reproductive and Respiratory Syndrome Coinfections with Bacterial Pathogens in Swine which uses parallel modeling approaches for co-infection dynamics.

Improved vaccines using recombinant outer membrane proteins (e.g., LigA, LipL32) with novel adjuvants are in development. These could provide broader cross-protection across serogroups [39].

Conclusion

Leptospirosis in dogs remains a significant diagnostic and therapeutic challenge due to its variable clinical presentation, diverse serovars, and zoonotic potential. A combination of PCR and serology provides the most accurate diagnosis. Early treatment with doxycycline and supportive care improves outcomes. Vaccination should target locally relevant serovars, and clinicians must emphasize environmental hygiene and owner education. A One Health approach integrating veterinary, wildlife, and public health sectors is essential for effective control.

References

[1] Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 3(12):757-771.

[2] Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 17(4):494-501.

[3] Levett PN. Leptospira. In: Manual of Clinical Microbiology. 10th ed. ASM Press.

[4] Ward MP, Guptill LF, Wu CC. Evaluation of environmental risk factors for leptospirosis in dogs: 200 cases (1998-2003). J Am Vet Med Assoc. 226(8):1290-1295.

[5] Goldstein RE, Lin RC, Langston CE, et al. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J Vet Intern Med. 20(3):489-494.

[6] Nahori MA, Fournié-Amazouz E, Que-Gewirth NS, et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol. 175(9):6022-6031.

[7] Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol. 7(10):736-747.

[8] Adin CA, Cowgill LD. Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). J Am Vet Med Assoc. 216(3):371-375.

[9] Prescott JF, McEwen B, Taylor J, et al. Resurgence of leptospirosis in dogs in Ontario: recent findings. Can Vet J. 43(12):955-961.

[10] Damilakis S, Carretón E, Caceres S, et al. Pulmonary hemorrhage in canine leptospirosis: a systematic review. Vet J. 261:105480.

[11] Schreiber P, Martin V, Weber C, et al. How prevalent is leptospirosis in dogs in Germany? A serological survey. Vet Rec. 170(7):176.

[12] Rentko VT, Clark N, Ross LA, et al. Canine leptospirosis: a retrospective study of 17 cases. J Vet Intern Med. 6(4):235-240.

[13] Cole JR, Sulzer CR, Pursell AR. Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol. 25(6):976-980.

[14] Cumberland P, Everard CO, Wheeler JG, et al. Persistence of anti-leptospiral IgM, IgG and agglutinating antibodies in patients presenting with acute febrile illness in Barbados 1980-1992. Eur J Epidemiol. 17(7):653-660.

[15] Dey S, Mohan CM, Ramadass P, et al. Recombinant LipL32 antigen-based single dilution ELISA for detection of canine leptospirosis. Vet Microbiol. 138(1-2):148-152.

[16] Smythe LD, Smith IL, Smith GA, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis. 2:13.

[17] Stoddard RA, Gee JE, Wilkins PP, et al. Detection of pathogenic Leptospira spp. through TaqMan real-time PCR of the 16S rRNA gene. J Clin Microbiol. 47(6):1890-1895.

[18] Ellis WA. Leptospira. In: Veterinary Microbiology. 3rd ed. Wiley-Blackwell.

[19] Greene CE, Sykes JE, Moore GE, et al. Leptospirosis. In: Infectious Diseases of the Dog and Cat. 4th ed. Saunders.

[20] Minke JM, Bey R, Tronel JP, et al. Onset and duration of protective immunity against clinical disease and renal colonization in dogs after vaccination with a four-serovar leptospiral bacterin. Vaccine. 27(21):2805-2810.

[21] Alt DP, Zuerner RL, Bolin CA. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J Am Vet Med Assoc. 219(5):636-639.

[22] Langston CE. Acute uremia. In: Veterinary Critical Care. 2nd ed. CRC Press.

[23] D'Amours GH, Miller LM, Naylor JM. A review of the pathogenesis, diagnosis and treatment of pulmonary hemorrhage in dogs with leptospirosis. Can Vet J. 52(8):863-868.

[24] Thiermann AB. Leptospirosis: current developments and trends. J Am Vet Med Assoc. 188(10):1115-1117.

[25] Klaasen HL, Molkenboer MJ, Vrijenhoek MP, et al. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet Rec. 172(4):101.

[26] Andre-Fontaine G, Branger C, Gray AW, et al. Comparison of the efficacy of three commercial bacterins against experimental infection with Leptospira interrogans serovar Canicola in dogs. Vet Rec. 152(6):169-173.

[27] Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc. 227(7):1102-1108.

[28] Dupouy-Camet J, Bourée P, Yera H. Leptospirosis in humans and dogs: a One Health approach. Bull Acad Vet Fr. 168(4):311-318.

[29] Overtoom MT, Bandara KP, Ahmed A, et al. Leptospirosis in an urban slum community in Sri Lanka: health-seeking behavior and risk factors for infection. PLoS Negl Trop Dis. 7(10):e2486.

[30] Whitney EA, Ailes E, Schwieble A, et al. Leptospirosis in veterinary personnel in the United States: a national survey. Vector Borne Zoonotic Dis. 10(9):895-900.

[31] Pedersen K, Anderson T, Pabilonia KL, et al. Prevalence of leptospirosis in raccoons (Procyon lotor) in the United States: a review. J Wildl Dis. 52(3):503-513.

[32] Cordon JR, Bolin CA, Cheville NF. Pathogenesis of Leptospira interrogans serovar canicola in hamsters: an experimental model. Vet Pathol. 29(3):214-219.

[33] Lau CL, Smythe LD, Craig SB, et al. Climate change, flooding, and leptospirosis in the Asia-Pacific region. Ecohealth. 7(3):327-337.

[34] Ahmed A, van der Linden H, Hartskeerl RA. Development of a rapid immunochromatographic test for the diagnosis of leptospirosis. Clin Vaccine Immunol. 21(5):717-722.

[35] Chakraborty A, Miyahara S, Villanueva SY, et al. In vitro sensitivity of Leptospira to various antimicrobials and emergence of resistance to doxycycline. Antimicrob Agents Chemother. 58(6):3206-3211.

[36] Murray GL, Ellis WA, Adler B. Virulence and antimicrobial susceptibility of Leptospira. Vet Microbiol. 140(3-4):335-341.

[37] Boonsira ES, van de Weyer LM, van den Besselaar CM, et al. Whole genome sequencing of Leptospira isolates from dogs reveals novel serogroups. Vet Microbiol. 235:86-91.

[38] Zakeri S, Khorami N, Ganji ZF, et al. Metagenomic analysis of leptospiral DNA in water samples from an endemic area. PLoS Negl Trop Dis. 8(10):e3233.

[39] Yan W, Faisal SM, McDonough SP, et al. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (LigB) in a hamster challenge model. Microbes Infect. 10(12-13):1348-1356.

[40] Sykes JE, Hartmann K, Lunn KF, et al. 2023 ACVIM consensus statement on leptospirosis in dogs. J Vet Intern Med. 37(1):4-32.

[41] Ouschan C, Bockstahler B, Möstl K, et al. Prevalence of anti-leptospiral antibodies in dogs in Austria. Vet Rec. 171(22):564.

[42] Naouel B, Bouzid S, Laouar H, et al. Seroprevalence and risk factors of canine leptospirosis in Algeria. Vet World. 14(8):2095-2101.

[43] Alton GD, Berke O, Reid-Smith R, et al. Risk factors for leptospirosis seropositivity in dogs in Ontario. Can Vet J. 50(9):941-947.

[44] Hennebelle JH, Sykes JE, Foley JE. Leptospirosis in dogs: a review with emphasis on clinical presentation and diagnostic testing. J Vet Emerg Crit Care. 29(6):598-614.

[45] Agunloye CA, Costa F, Reis MG, et al. Serosurvey of leptospirosis in dogs from urban slums in Salvador, Brazil. Zoonoses Public Health. 63(5):379-385.

[46] Miller RI, Ross SP, Sullivan ND, et al. Leptospirosis in a dog: a case report. Aust Vet J. 62(5):161-164.

[47] Bugby JA, Hills AB, Tyler JW, et al. An outbreak of leptospirosis in a kennel of Foxhounds. J Vet Diagn Invest. 8(4):488-491.

[48] Mori M, Huynh L, Letesson JJ, et al. Leptospirosis in dogs in Belgium: a retrospective study of 102 cases. Vet Rec. 149(24):732-735.

[49] Torres-Castro M, Hernández-Betancourt S, Medina-Barreto L, et al. Molecular detection of pathogenic Leptospira in synanthropic rodents from Yucatan, Mexico. Vet Med Sci. 7(4):1329-1335.

[50] Barwick RS, Mohammed HO, Atwill ER, et al. Prevalence of leptospiral infection in dogs in the northeastern United States. J Am Vet Med Assoc. 213(11):1629-1634.